Clinical Trial Update: Phase 3 /Seroquel SR Acute Mania Monotherapy - US [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating quetiapine extended-release (Seroquel SR) as monotherapy for acute mania in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Manic Episode

Drugs mentioned

• Seroquel SR (quetiapine extended-release)

Snippet

Sponsor: AstraZeneca | Conditions: Affective Psychosis, Bipolar, Manic Disorder | Phase 3 | Status: COMPLETED